Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for ORIC

Stock Name	Oric Pharmaceuticals Inc
Ticker	ORIC(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US68622P1093
LEI	54930033FJRNEYBW0L25

Show aggregate ORIC holdings

News associated with ORIC

Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Rating of “Moderate Buy” from Analysts: Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received an average rating of “Moderate Buy” from the nine brokerages that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price target […] - 2025-09-19 03:15:02
Brokerages Set Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Price Target at $17.63: Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 12-month […] - 2025-08-28 03:12:47
JPMorgan Chase & Co. Has Lowered Expectations for Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price: Oric Pharmaceuticals (NASDAQ:ORIC – Free Report) had its price target decreased by JPMorgan Chase & Co. from $20.00 to $17.00 in a research report sent to investors on Thursday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. ORIC has been the subject of a number of other reports. Oppenheimer lowered […] - 2025-08-15 04:52:49
Victory Capital Management Inc. Has $838,000 Position in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC): Victory Capital Management Inc. raised its holdings in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 54.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 150,260 shares of the company’s stock after buying an additional 52,760 shares during the period. Victory Capital Management Inc.’s […] - 2025-08-01 05:01:17
Arizona State Retirement System Purchases New Position in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC): Arizona State Retirement System purchased a new stake in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) during the first quarter, Holdings Channel reports. The institutional investor purchased 10,088 shares of the company’s stock, valued at approximately $56,000. A number of other hedge funds have also modified their holdings of ORIC. Vanguard Group Inc. increased its […] - 2025-07-24 04:38:53
LADENBURG THALM/SH SH Initiates Coverage on Oric Pharmaceuticals (NASDAQ:ORIC): LADENBURG THALM/SH SH assumed coverage on shares of Oric Pharmaceuticals (NASDAQ:ORIC – Free Report) in a report released on Tuesday, MarketBeat.com reports. The brokerage issued a buy rating and a $15.00 price target on the stock. Several other equities research analysts have also recently weighed in on ORIC. Oppenheimer decreased their price objective on Oric […] - 2025-07-11 02:36:47
Brokerages Set Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Price Target at $19.17: Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have received an average rating of “Buy” from the nine brokerages that are covering the stock, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have issued a report on the stock […] - 2025-07-09 02:33:02
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up After Insider Buying Activity: Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) shares gapped up prior to trading on Tuesday following insider buying activity. The stock had previously closed at $10.00, but opened at $10.63. Oric Pharmaceuticals shares last traded at $10.87, with a volume of 484,723 shares. Specifically, Director Angie You acquired 26,597 shares of the firm’s stock […] - 2025-06-25 02:22:47
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 54.5% during the fourth quarter, Holdings Channel reports. The fund owned 35,579 shares of the company’s stock after purchasing an additional 12,545 shares during the quarter. UBS AM a […] - 2025-06-13 04:32:47
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Recommendation of “Buy” by Analysts: Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have been assigned an average rating of “Buy” from the eight research firms that are currently covering the company, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have covered the stock […] - 2025-06-11 03:08:48
Thursday's ETF Movers: XBI, URA: In trading on Thursday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 1.9% on the day. Components of that ETF showing particular strength include shares of Oric Pharmaceuticals, up about 33.8% and shares of Replimune Group, up about 9.6% on the day. And un - 2025-05-29 12:59:01
Janus Henderson Group PLC Makes New Investment in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC): Janus Henderson Group PLC acquired a new stake in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 14,600 shares of the company’s stock, valued at approximately $118,000. Several other institutional investors have also recently modified their holdings of the company. KLP Kapitalforvaltning AS purchased a […] - 2025-05-26 04:51:01
Brokerages Set ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Target Price at $19.17: Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have been assigned an average rating of “Buy” from the eight brokerages that are covering the firm, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have updated their coverage on […] - 2025-05-22 05:30:55
Tower Research Capital LLC TRC Purchases 13,384 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC): Tower Research Capital LLC TRC lifted its position in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 1,048.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,661 shares of the company’s stock after purchasing an additional 13,384 shares during the quarter. […] - 2025-05-09 05:21:00
MetLife Investment Management LLC Purchases 5,530 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC): MetLife Investment Management LLC grew its position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 15.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 41,608 shares of the company’s stock after acquiring an additional 5,530 shares during the period. MetLife Investment […] - 2025-05-07 05:28:51
HC Wainwright Reiterates Buy Rating for ORIC Pharmaceuticals (NASDAQ:ORIC): ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $21.00 price target on the stock. HC Wainwright’s price target suggests a potential upside of 316.67% from the stock’s previous close. Other analysts […] - 2025-05-07 02:58:49
XTX Topco Ltd Has $210,000 Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC): XTX Topco Ltd increased its holdings in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 120.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 25,966 shares of the company’s stock after acquiring an additional 14,209 shares during the period. XTX […] - 2025-04-28 05:11:12
Brokerages Set ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) PT at $18.86: ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received a consensus recommendation of “Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. Nine research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have covered the stock in the last year […] - 2025-04-25 02:32:47
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Acquired by Wellington Management Group LLP: Wellington Management Group LLP increased its holdings in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 6.9% during the fourth quarter, HoldingsChannel reports. The fund owned 186,430 shares of the company’s stock after buying an additional 12,042 shares during the period. Wellington Management Group LLP’s holdings in ORIC Pharmaceuticals were worth $1,504,000 at […] - 2025-04-14 04:45:06
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives $18.86 Consensus PT from Brokerages: ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has been assigned an average rating of “Buy” from the nine research firms that are covering the stock, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have covered the stock in […] - 2025-03-31 02:32:43
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up Following Better-Than-Expected Earnings: ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) shares gapped up prior to trading on Wednesday following a better than expected earnings announcement. The stock had previously closed at $7.85, but opened at $8.57. ORIC Pharmaceuticals shares last traded at $7.99, with a volume of 78,926 shares traded. The company reported ($0.51) EPS for the […] - 2025-02-21 04:56:45
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Rating of “Buy” from Analysts: ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received an average recommendation of “Buy” from the nine research firms that are presently covering the stock, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have issued a report on the stock in […] - 2025-02-11 06:30:52

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc ORIC holdings

Date	Number of ORIC Shares Held	Base Market Value of ORIC Shares	Local Market Value of ORIC Shares	Change in ORIC Shares Held	Change in ORIC Base Value	Current Price per ORIC Share Held	Previous Price per ORIC Share Held
2025-12-11 (Thursday)	9,849	USD 95,437	USD 95,437	0	USD -3,053	USD 9.69002	USD 10
2025-12-10 (Wednesday)	9,849	USD 98,490	USD 98,490	0	USD -1,379	USD 10	USD 10.14
2025-12-09 (Tuesday)	9,849	USD 99,869	USD 99,869	0	USD -3,742	USD 10.14	USD 10.52
2025-12-08 (Monday)	9,849	USD 103,611	USD 103,611	0	USD -4,728	USD 10.52	USD 11
2025-12-05 (Friday)	9,849	USD 108,339	USD 108,339	0	USD -3,841	USD 11	USD 11.39
2025-12-04 (Thursday)	9,849	USD 112,180	USD 112,180	0	USD 4,038	USD 11.39	USD 10.98
2025-12-03 (Wednesday)	9,849	USD 108,142	USD 108,142	-175	USD 1,386	USD 10.98	USD 10.65
2025-12-02 (Tuesday)	10,024	USD 106,756	USD 106,756	70	USD -4,231	USD 10.65	USD 11.15
2025-12-01 (Monday)	9,954	USD 110,987	USD 110,987	0	USD -7,267	USD 11.15	USD 11.88
2025-11-28 (Friday)	9,954	USD 118,254	USD 118,254	0	USD 598	USD 11.88	USD 11.82
2025-11-27 (Thursday)	9,954	USD 117,656	USD 117,656	0	USD 0	USD 11.82	USD 11.82
2025-11-26 (Wednesday)	9,954	USD 117,656	USD 117,656	0	USD 1,991	USD 11.82	USD 11.62
2025-11-25 (Tuesday)	9,954	USD 115,665	USD 115,665	-105	USD -2,931	USD 11.62	USD 11.79

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ORIC by Blackrock for IE00B3VWM098

Show aggregate share trades of ORIC

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-03 SELL -175 11.055 10.570 10.618 USD -1,858 8.48 Loss of -374 on sale
2025-12-02 BUY 70 11.245 10.445 10.525 USD 737 8.46
2025-11-25 SELL -105 12.290 11.470 11.552 USD -1,213 8.30 Loss of -342 on sale
2025-11-24 SELL -105 12.005 11.500 11.551 USD -1,213 8.26 Loss of -345 on sale
2025-11-17 SELL -385 12.710 11.280 11.423 USD -4,398 8.08 Loss of -1,287 on sale
2025-11-12 SELL -35 12.965 12.390 12.448 USD -436 7.94 Loss of -158 on sale
2025-11-06 SELL -35 12.910 12.160 12.235 USD -428 7.73 Loss of -158 on sale
2025-11-05 SELL -350 12.540 11.880 11.946 USD -4,181 7.67 Loss of -1,495 on sale
2025-11-04 SELL -70 12.710 12.160 12.215 USD -855 7.62 Loss of -322 on sale
2025-11-03 SELL -70 13.420 12.260 12.376 USD -866 7.56 Loss of -337 on sale
2025-10-28 BUY 105 13.430 13.810 13.772 USD 1,446 7.28
2025-10-24 SELL -35 13.100 13.380 13.352 USD -467 7.12 Loss of -218 on sale
2025-10-15 BUY 210 13.900 14.040 14.026 USD 2,945 6.57
2025-10-02 BUY 35 11.320 11.839 11.787 USD 413 6.43
2025-09-30 BUY 70 12.000 12.050 12.045 USD 843 6.26
2025-05-23 BUY 47 6.350 6.450 6.440 USD 303 5.92
2025-05-19 SELL -47 5.140 5.190 5.185 USD -244 5.94 Profit of 36 on sale
2025-05-15 SELL -141 4.740 4.850 4.839 USD -682 5.99 Profit of 162 on sale
2025-05-12 SELL -47 5.410 5.540 5.527 USD -260 6.04 Profit of 24 on sale
2025-05-09 SELL -47 5.080 5.590 5.539 USD -260 6.06 Profit of 24 on sale
2025-04-30 SELL -47 5.710 5.780 5.773 USD -271 6.17 Profit of 19 on sale
2025-04-24 SELL -94 5.190 5.260 5.253 USD -494 6.27 Profit of 96 on sale
2025-04-17 SELL -47 4.770 4.895 4.882 USD -229 6.48 Profit of 75 on sale
2025-04-15 SELL -141 5.040 5.380 5.346 USD -754 6.58 Profit of 174 on sale
2025-04-14 SELL -141 5.110 5.170 5.164 USD -728 6.63 Profit of 207 on sale
2025-04-09 SELL -188 4.690 5.040 5.005 USD -941 6.86 Profit of 350 on sale
2025-04-07 SELL -329 4.590 5.010 4.968 USD -1,634 7.07 Profit of 691 on sale
2025-04-04 SELL -480 4.880 5.180 5.150 USD -2,472 7.16 Profit of 966 on sale
2025-03-31 BUY 48 5.580 5.890 5.859 USD 281 7.39
2025-03-19 SELL -96 7.470 7.720 7.695 USD -739 7.79 Profit of 9 on sale
2025-03-14 SELL -288 7.790 7.960 7.943 USD -2,288 7.79 Loss of -44 on sale
2025-03-13 SELL -96 7.700 8.080 8.042 USD -772 7.80 Loss of -23 on sale
2025-03-12 SELL -1,632 8.000 8.110 8.099 USD -13,218 7.77 Loss of -530 on sale
2025-03-07 SELL -96 8.000 8.040 8.036 USD -771 7.77 Loss of -25 on sale
2025-03-06 SELL -144 7.850 8.110 8.084 USD -1,164 7.75 Loss of -48 on sale
2025-03-03 SELL -48 7.640 8.158 8.106 USD -389 0.00 Loss of -389 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-03	SELL	-175	11.055	10.570	10.618	USD -1,858	8.48 Loss of -374 on sale
2025-12-02	BUY	70	11.245	10.445	10.525	USD 737	8.46
2025-11-25	SELL	-105	12.290	11.470	11.552	USD -1,213	8.30 Loss of -342 on sale
2025-11-24	SELL	-105	12.005	11.500	11.551	USD -1,213	8.26 Loss of -345 on sale
2025-11-17	SELL	-385	12.710	11.280	11.423	USD -4,398	8.08 Loss of -1,287 on sale
2025-11-12	SELL	-35	12.965	12.390	12.448	USD -436	7.94 Loss of -158 on sale
2025-11-06	SELL	-35	12.910	12.160	12.235	USD -428	7.73 Loss of -158 on sale
2025-11-05	SELL	-350	12.540	11.880	11.946	USD -4,181	7.67 Loss of -1,495 on sale
2025-11-04	SELL	-70	12.710	12.160	12.215	USD -855	7.62 Loss of -322 on sale
2025-11-03	SELL	-70	13.420	12.260	12.376	USD -866	7.56 Loss of -337 on sale
2025-10-28	BUY	105	13.430	13.810	13.772	USD 1,446	7.28
2025-10-24	SELL	-35	13.100	13.380	13.352	USD -467	7.12 Loss of -218 on sale
2025-10-15	BUY	210	13.900	14.040	14.026	USD 2,945	6.57
2025-10-02	BUY	35	11.320	11.839	11.787	USD 413	6.43
2025-09-30	BUY	70	12.000	12.050	12.045	USD 843	6.26
2025-05-23	BUY	47	6.350	6.450	6.440	USD 303	5.92
2025-05-19	SELL	-47	5.140	5.190	5.185	USD -244	5.94 Profit of 36 on sale
2025-05-15	SELL	-141	4.740	4.850	4.839	USD -682	5.99 Profit of 162 on sale
2025-05-12	SELL	-47	5.410	5.540	5.527	USD -260	6.04 Profit of 24 on sale
2025-05-09	SELL	-47	5.080	5.590	5.539	USD -260	6.06 Profit of 24 on sale
2025-04-30	SELL	-47	5.710	5.780	5.773	USD -271	6.17 Profit of 19 on sale
2025-04-24	SELL	-94	5.190	5.260	5.253	USD -494	6.27 Profit of 96 on sale
2025-04-17	SELL	-47	4.770	4.895	4.882	USD -229	6.48 Profit of 75 on sale
2025-04-15	SELL	-141	5.040	5.380	5.346	USD -754	6.58 Profit of 174 on sale
2025-04-14	SELL	-141	5.110	5.170	5.164	USD -728	6.63 Profit of 207 on sale
2025-04-09	SELL	-188	4.690	5.040	5.005	USD -941	6.86 Profit of 350 on sale
2025-04-07	SELL	-329	4.590	5.010	4.968	USD -1,634	7.07 Profit of 691 on sale
2025-04-04	SELL	-480	4.880	5.180	5.150	USD -2,472	7.16 Profit of 966 on sale
2025-03-31	BUY	48	5.580	5.890	5.859	USD 281	7.39
2025-03-19	SELL	-96	7.470	7.720	7.695	USD -739	7.79 Profit of 9 on sale
2025-03-14	SELL	-288	7.790	7.960	7.943	USD -2,288	7.79 Loss of -44 on sale
2025-03-13	SELL	-96	7.700	8.080	8.042	USD -772	7.80 Loss of -23 on sale
2025-03-12	SELL	-1,632	8.000	8.110	8.099	USD -13,218	7.77 Loss of -530 on sale
2025-03-07	SELL	-96	8.000	8.040	8.036	USD -771	7.77 Loss of -25 on sale
2025-03-06	SELL	-144	7.850	8.110	8.084	USD -1,164	7.75 Loss of -48 on sale
2025-03-03	SELL	-48	7.640	8.158	8.106	USD -389	0.00 Loss of -389 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ORIC

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	312,228	0	401,879	77.7%
2025-09-18	189,657	0	290,975	65.2%
2025-09-17	196,609	14,866	429,152	45.8%
2025-09-16	274,498	0	389,947	70.4%
2025-09-15	387,562	0	505,219	76.7%
2025-09-12	251,354	6,075	360,700	69.7%
2025-09-11	237,238	0	345,079	68.7%
2025-09-10	189,615	1,200	348,872	54.4%
2025-09-09	202,517	0	489,465	41.4%
2025-09-08	190,429	13	673,706	28.3%
2025-09-05	220,381	0	414,071	53.2%
2025-09-04	304,820	1,583	396,666	76.8%
2025-09-03	378,351	0	582,115	65.0%
2025-09-02	347,552	500	460,872	75.4%
2025-08-29	132,676	8,741	184,959	71.7%
2025-08-28	252,617	9,695	348,713	72.4%
2025-08-27	443,856	5,237	598,989	74.1%
2025-08-26	69,162	2,101	120,962	57.2%
2025-08-25	71,407	0	95,995	74.4%
2025-08-22	51,482	0	129,364	39.8%
2025-08-21	50,222	6,825	84,078	59.7%
2025-08-20	65,495	1,000	121,842	53.8%
2025-08-19	186,833	3,710	256,467	72.8%
2025-08-18	113,078	5,618	265,954	42.5%
2025-08-15	112,386	0	206,420	54.4%
2025-08-14	122,605	0	253,393	48.4%
2025-08-13	149,475	0	313,247	47.7%
2025-08-12	92,121	0	220,668	41.7%
2025-08-11	97,201	278	354,903	27.4%
2025-08-08	130,729	0	412,447	31.7%
2025-08-07	60,691	0	124,467	48.8%
2025-08-06	157,508	0	315,626	49.9%
2025-08-05	76,490	107	253,979	30.1%
2025-08-04	93,011	0	337,798	27.5%
2025-08-01	114,467	0	258,999	44.2%
2025-07-31	107,706	0	281,923	38.2%
2025-07-30	84,556	4,853	273,223	30.9%
2025-07-29	428,791	9,573	11,399,691	3.8%
2025-07-28	77,789	0	204,391	38.1%
2025-07-25	97,411	34	171,611	56.8%
2025-07-24	54,925	0	80,945	67.9%
2025-07-23	130,177	0	426,525	30.5%
2025-07-22	63,882	0	150,848	42.3%
2025-07-21	98,951	0	199,243	49.7%
2025-07-18	113,548	0	149,797	75.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE